Valsartan NDC 51660-140

NDC codes

FDA NDC Directory

Product NDC (as listed)51660-140Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51660-0140Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
51660-140-03	51660014003	10 TABLET, FILM COATED in 1 BOTTLE (51660-140-03)Marketed from Jul 7, 2014
51660-140-05	51660014005	500 TABLET, FILM COATED in 1 BOTTLE (51660-140-05)Marketed from Jul 7, 2014
51660-140-30	51660014030	30 TABLET, FILM COATED in 1 BOTTLE (51660-140-30)Marketed from Jul 7, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Valsartan
Generic name (nonproprietary): valsartan
Active ingredients: Valsartan — 40 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Ohm Laboratories Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077492
Marketing start: Jul 7, 2014
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 51660-140_5863dfd5-e750-5523-e063-6294a90a9ef9SPL ID 5863dfd5-e750-5523-e063-6294a90a9ef9SPL set ID ab5e0e5a-5bdf-4cfc-9d18-57ea4d642f65RxCUI 349199, 349200, 349201, 349483UNII 80M03YXJ7IUPC 0351660140309
Pharmacologic class: Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451660014003 followed by a unit qualifier and the quantity

Package 51660-0140-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 6, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Valsartan tablets are an angiotensin II receptor blocker (ARB) indicated for: Hypertension , to lower blood pressure in adults and children 6 years and older. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions ( 1.1 ) Heart failure (NYHA class II-IV) , to reduce hospitalization for heart failure in adults ( 1.2 ) Post-myocardial infarction , for the reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction in adults ( 1.3 ) 1.1 Hypertension Valsartan tablets are indicated for the treatment of hypertension, to l…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077492

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077492
Product	Strength	Form · route	Labeler	Product NDC
Valsartan	Valsartan 80 mg/1	Tablet, Film coatedOral	Ohm Laboratories Inc.	51660-141
Valsartan	Valsartan 160 mg/1	Tablet, Film coatedOral	Ohm Laboratories Inc.	51660-142
Valsartan	Valsartan 320 mg/1	Tablet, Film coatedOral	Ohm Laboratories Inc.	51660-143